These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36917518)

  • 1. Burden of Disease and Unmet Needs in Atopic Dermatitis: Results From a Patient Survey.
    Silverberg JI; Mohawk JA; Cirulli J; Nograles K; Punzalan JC; Kelly KM; Kim BS; Guttman-Yassky E; Lebwohl M
    Dermatitis; 2023; 34(2):135-144. PubMed ID: 36917518
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of Inadequately Controlled Disease and Disease Severity With Patient-Reported Disease Burden in Adults With Atopic Dermatitis.
    Simpson EL; Guttman-Yassky E; Margolis DJ; Feldman SR; Qureshi A; Hata T; Mastey V; Wei W; Eckert L; Chao J; Arnold RJG; Yu T; Vekeman F; Suárez-Fariñas M; Gadkari A
    JAMA Dermatol; 2018 Aug; 154(8):903-912. PubMed ID: 29971354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline Body Surface Area and Itch Severity Define Response to Baricitinib in Patients with Moderate-to-Severe Atopic Dermatitis at Week 16.
    Thyssen JP; de Bruin-Weller M; Costanzo A; Grond S; Schuster C; Liu C; Rueda MJ; Chen YF; Pinter A; Bieber T
    Adv Ther; 2023 Aug; 40(8):3574-3587. PubMed ID: 37332021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peak Pruritus Numerical Rating Scale: psychometric validation and responder definition for assessing itch in moderate-to-severe atopic dermatitis.
    Yosipovitch G; Reaney M; Mastey V; Eckert L; Abbé A; Nelson L; Clark M; Williams N; Chen Z; Ardeleanu M; Akinlade B; Graham NMH; Pirozzi G; Staudinger H; Plaum S; Radin A; Gadkari A
    Br J Dermatol; 2019 Oct; 181(4):761-769. PubMed ID: 30729499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing Itch Severity: Content Validity and Psychometric Properties of a Patient-Reported Pruritus Numeric Rating Scale in Atopic Dermatitis.
    Rams A; Baldasaro J; Bunod L; Delbecque L; Strzok S; Meunier J; ElMaraghy H; Sun L; Pierce E
    Adv Ther; 2024 Apr; 41(4):1512-1525. PubMed ID: 38363461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychometric properties of the itch numeric rating scale, skin pain numeric rating scale, and atopic dermatitis sleep scale in adult patients with moderate-to-severe atopic dermatitis.
    Silverberg JI; DeLozier A; Sun L; Thyssen JP; Kim B; Yosipovitch G; Nunes FP; Gugiu PC; Doll HA; Eichenfield LF
    Health Qual Life Outcomes; 2021 Oct; 19(1):247. PubMed ID: 34688290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment satisfaction of adult patients with moderate-to-severe atopic dermatitis treated with baricitinib in France, Germany, and the United Kingdom: results from a cross-sectional international patient survey.
    Augustin M; Nosbaum A; Werfel T; Grond S; Reed C; Lampropoulou A; Tietz N; Irvine AD; Riedl E
    J Dermatolog Treat; 2023 Dec; 34(1):2276047. PubMed ID: 37965779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of itch and skin pain on quality of life in adult patients with atopic dermatitis in Japan: results from a real-world, point-in-time, survey of physicians and patients.
    Torisu-Itakura H; Anderson P; Piercy J; Pike J; Sakamoto A; Kabashima K
    Curr Med Res Opin; 2022 Aug; 38(8):1401-1410. PubMed ID: 35787197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-Reported Disease Burden and Unmet Therapeutic Needs in Atopic Dermatitis.
    Bacci E; Rentz A; Correll J; Pierce E; DeLozier A; Rueda M; Begolka W; Butler L
    J Drugs Dermatol; 2021 Nov; 20(11):1222-1230. PubMed ID: 34784136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burden of adult atopic dermatitis and unmet needs with existing therapies.
    Bacci ED; Correll JR; Pierce EJ; Atwater AR; Dawson Z; Begolka WS; Butler L
    J Dermatolog Treat; 2023 Dec; 34(1):2202288. PubMed ID: 37042571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of itch triggers with atopic dermatitis severity and course in adults.
    Silverberg JI; Lei D; Yousaf M; Janmohamed SR; Vakharia PP; Chopra R; Chavda R; Gabriel S; Patel KR; Singam V; Kantor R; Hsu DY; Cella D
    Ann Allergy Asthma Immunol; 2020 Nov; 125(5):552-559.e2. PubMed ID: 32544530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Burden of skin pain in atopic dermatitis.
    Vakharia PP; Chopra R; Sacotte R; Patel KR; Singam V; Patel N; Immaneni S; White T; Kantor R; Hsu DY; Silverberg JI
    Ann Allergy Asthma Immunol; 2017 Dec; 119(6):548-552.e3. PubMed ID: 29223299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Onset of Symptom Relief Reported in Daily Diaries of Patients With Atopic Dermatitis Treated With Baricitinib in a United States Clinical Trial (BREEZE-AD5).
    Rosmarin D; Casillas M; Chen S; Dawson Z; Pierce E; Zhang H; Bukhalo M; Smith S
    J Cutan Med Surg; 2022; 26(3):262-266. PubMed ID: 35086348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease burden among patients with atopic dermatitis treated with systemic therapy for 4-12 months: results from the CorEvitas Atopic Dermatitis Registry.
    Silverberg JI; Pierce E; Feely M; Atwater AR; Schrader A; Jones EA; Dave SS; Simpson EL
    J Dermatolog Treat; 2023 Dec; 34(1):2246601. PubMed ID: 37691405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A real-world study evaluating adeQUacy of Existing Systemic Treatments for patients with moderate-to-severe Atopic Dermatitis (QUEST-AD): Baseline treatment patterns and unmet needs assessment.
    Wei W; Ghorayeb E; Andria M; Walker V; Schnitzer J; Kennedy M; Chen Z; Belland A; White J; Silverberg JI
    Ann Allergy Asthma Immunol; 2019 Oct; 123(4):381-388.e2. PubMed ID: 31325566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvements in itch and sleep following treatment with baricitinib in combination with topical corticosteroids are associated with better quality of life and productivity in adult patients with moderate-to-severe atopic dermatitis: a post hoc analysis from BREEZE-AD7.
    Masuda K; Delozier AM; Kolodsick J; Buchanan A; Pink AE; Sun L; Wang Z; Stingeni L; Thac I D
    Eur J Dermatol; 2022 Apr; 32(2):237-243. PubMed ID: 35866910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical phenotyping of atopic dermatitis using combined itch and lesional severity: A prospective observational study.
    Chovatiya R; Lei D; Ahmed A; Chavda R; Gabriel S; Silverberg JI
    Ann Allergy Asthma Immunol; 2021 Jul; 127(1):83-90.e2. PubMed ID: 33819616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severity strata for five patient-reported outcomes in adults with atopic dermatitis.
    Vakharia PP; Chopra R; Sacotte R; Patel N; Immaneni S; White T; Kantor R; Hsu DY; Simpson EL; Silverberg JI
    Br J Dermatol; 2018 Apr; 178(4):925-930. PubMed ID: 29048751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baricitinib improves symptoms in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: patient-reported outcomes from two randomized monotherapy phase III trials.
    Reich K; DeLozier AM; Nunes FP; Thyssen JP; Eichenfield LF; Wollenberg A; Ross Terres JA; Watts SD; Chen YF; Simpson EL; Silverberg JI
    J Dermatolog Treat; 2022 May; 33(3):1521-1530. PubMed ID: 33222559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of Pruritus in Relation to Self-assessed Severity of Atopic Dermatitis.
    Huet F; Faffa MS; Poizeau F; Merhand S; Misery L; Brenaut E
    Acta Derm Venereol; 2019 Mar; 99(3):279-283. PubMed ID: 30264161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.